[go: up one dir, main page]

NO20071044L - Doseformer med enteraltbelagte tablettkjerner - Google Patents

Doseformer med enteraltbelagte tablettkjerner

Info

Publication number
NO20071044L
NO20071044L NO20071044A NO20071044A NO20071044L NO 20071044 L NO20071044 L NO 20071044L NO 20071044 A NO20071044 A NO 20071044A NO 20071044 A NO20071044 A NO 20071044A NO 20071044 L NO20071044 L NO 20071044L
Authority
NO
Norway
Prior art keywords
coated tablet
present
dosage forms
patient
tablet cores
Prior art date
Application number
NO20071044A
Other languages
English (en)
Norwegian (no)
Inventor
Moshe Flashner-Barak
E Itzhak Lerner
Vered Rosenberger
Ofer Aqua
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20071044L publication Critical patent/NO20071044L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20071044A 2004-07-26 2007-02-23 Doseformer med enteraltbelagte tablettkjerner NO20071044L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59148204P 2004-07-26 2004-07-26
US59182004P 2004-07-27 2004-07-27
PCT/US2005/026610 WO2006012634A1 (fr) 2004-07-26 2005-07-26 Formes posologiques avec comprimé à noyau pelliculé gastro-résistant

Publications (1)

Publication Number Publication Date
NO20071044L true NO20071044L (no) 2007-02-23

Family

ID=35229812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071044A NO20071044L (no) 2004-07-26 2007-02-23 Doseformer med enteraltbelagte tablettkjerner

Country Status (11)

Country Link
US (1) US20060153918A1 (fr)
EP (1) EP1663167A1 (fr)
KR (1) KR20070036797A (fr)
AU (1) AU2005266882A1 (fr)
BR (1) BRPI0513598A (fr)
CA (1) CA2575006A1 (fr)
EA (1) EA200700158A1 (fr)
IL (1) IL180883A0 (fr)
MX (1) MX2007001058A (fr)
NO (1) NO20071044L (fr)
WO (1) WO2006012634A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007056570A2 (fr) * 2005-11-07 2007-05-18 Teva Pharmaceutical Industries Ltd. Compositions de levodopa
MX2008011441A (es) * 2006-03-06 2008-11-18 Pozen Inc Formas de dosificacion para administrar combinaciones de farmacos.
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
JP2009536654A (ja) * 2006-05-09 2009-10-15 マリンクロッド・インコーポレイテッド ゼロ次放出改変固体投与形
CA2673485A1 (fr) * 2007-01-15 2008-07-24 Kissei Pharmaceutical Co., Ltd. Preparation de levodopa a liberation retardee du type a retention gastrique
EP1987816A1 (fr) * 2007-04-30 2008-11-05 Ratiopharm GmbH Adsorbate d'un sel de rasagiline en combinaison avec un agent inactive soluble dans l'eau
NZ586025A (en) * 2008-01-11 2012-08-31 Teva Pharma Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrate
US8080584B2 (en) * 2009-01-23 2011-12-20 Teva Pharmaceuticals Industries, Ltd. Delayed release rasagiline citrate formulation
US8313766B2 (en) * 2010-02-05 2012-11-20 Andrew Chen Oral antidepressant formulation with reduced excipient load
EP2844234B1 (fr) * 2012-04-27 2020-01-08 Merck Patent GmbH Comprimés pourvus d'un enrobage et leur fabrication
WO2014011830A1 (fr) 2012-07-12 2014-01-16 Mallinckrodt Llc Compositions pharmaceutiques de dissuasion d'abus à libération prolongée
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
ES2641308B1 (es) * 2016-05-05 2018-09-11 Products & Technology, S.L. Comprimidos de metilfenidato de liberación retardada
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109170C (fr) * 1958-02-03
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US6756056B2 (en) * 1997-04-08 2004-06-29 Alan A. Rubin Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
MXPA04002992A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Composicion comestible y forma de dosificacion que comprende una cubierta comestible.
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
MXPA04006310A (es) * 2001-12-24 2005-04-19 Teva Pharma Forma de dosis con una pastilla central de ingrediente activo revestido con un cuerpo anular comprimido de polvo o material granular y un proceso y maquinaria para fabricarla.
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
WO2004043431A1 (fr) * 2002-11-12 2004-05-27 Teva Pharmaceutical Industries Ltd. Compositions pharmaceutiques et formes posologiques pour administration par voie buccale et sublinguale de tizanidine et methodes d'administration par voie buccale ou sublinguale
EP1675651A1 (fr) * 2003-10-20 2006-07-05 Teva Pharmaceutical Industries Limited Composition et forme posologique pour un effet soutenu du levopoda

Also Published As

Publication number Publication date
AU2005266882A1 (en) 2006-02-02
CA2575006A1 (fr) 2006-02-02
WO2006012634A1 (fr) 2006-02-02
EA200700158A1 (ru) 2007-08-31
US20060153918A1 (en) 2006-07-13
BRPI0513598A (pt) 2008-05-13
MX2007001058A (es) 2007-04-16
KR20070036797A (ko) 2007-04-03
EP1663167A1 (fr) 2006-06-07
IL180883A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
CY1115484T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
ATE306266T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
EP1893182B8 (fr) Formes posologiques orales contenant de la progesterone et procede de fabrication et d'utilisation desdites formes posologiques
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
NO20051414L (no) Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger
CY1112256T1 (el) Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της
BR0211198A (pt) Composições farmacêuticas e seu uso
WO2008142572A3 (fr) Formulation de comprimé à libération contrôlée contenant de l'aluminométasilicate de magnésium
TW200738228A (en) Neramexane modified release matrix tablet
NO20073813L (no) Kladribinregime for behandling av multippel sklerose
EA200401097A1 (ru) Лекарственная форма с регулируемым высвобождением активного ингредиента
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
DK1711169T3 (da) Coatede mikrodepottabletter med venlafaxinhydrochlorid
MY146988A (en) Fexofenadine suspension formulation
WO2006040779A3 (fr) Formule à matrice flottante gastrique à libération contrôlée contenant la substance imatinib
BRPI0615195A8 (pt) preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida.
DE602004016963D1 (en) Therapeutisches system mit amoxicillin und clavulansäure
TW200700062A (en) Pharmaceutical compositions
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
DE602005008128D1 (de) Cytisinehaltiges Arzneimittel
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
MY142361A (en) Sustained-release pharmaceutical composition for pulmonary administration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application